SRRK

NASDAQ · Biotechnology

Scholar Rock Holding Corp

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$48.16

+1.51 (+3.24%)

As of Sep 21, 9:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 23 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target +48.0% upside

Low Target $54.07

Average Target $71.29

High Target $91.55

Current Price $48.16

Current
$48.16

Target
$71.29

$54.07 $71.29 avg $91.55

Scenario Analysis

Bear Case

$54.07

12.3%

Low target

Base Case

$71.29

+48.0%

Avg target

Bull Case

$91.55

+90.1%

High target

Risk/Reward

7.3x

Highly favorable

Price in Context

52-Week High

$61.76

-22.0% from high

52-Week Low

$27.07

+77.9% from low

50-Day SMA

$45.16

+6.6% vs SMA

200-Day SMA

$36.91

+30.5% vs SMA

RSI (14)

59.5

Neutral

Target vs 52W High

$71.29

+15.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%